» Articles » PMID: 15705661

Integration of the Extranuclear and Nuclear Actions of Estrogen

Overview
Journal Mol Endocrinol
Date 2005 Feb 12
PMID 15705661
Citations 277
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen receptors (ERs) are localized to many sites within the cell, potentially contributing to overall estrogen action. In the nucleus, estrogen mainly modulates gene transcription, and the resulting protein products determine the cell biological actions of the sex steroid. In addition, a small pool of ERs localize to the plasma membrane and signal mainly though coupling, directly or indirectly, to G proteins. In response to steroid, signal transduction modulates both nontranscriptional and transcriptional events and impacts both the rapid and more prolonged actions of estrogen. Cross-talk from membrane-localized ERs to nuclear ERs can be mediated through growth factor receptor tyrosine kinases, such as epidermal growth factor receptor and IGF-I receptor. Growth factor receptors enact signal transduction to kinases such as ERK and phosphatidylinositol 3-kinase that phosphorylate and activate nuclear ERs, and this can also occur in the absence of sex steroid. A complex relationship between the membrane and nuclear effects of estrogen also involves membrane-initiated phosphorylation of coactivators, recruiting these proteins to the nuclear transcriptosome. Finally, large pools of cytoplasmic ERs exist, and some are localized to mitochondria. The integration of sex steroid effects at distinct cellular locations of its receptor leads to important cellular physiological outcomes and are manifest in both reproductive and nonreproductive organs.

Citing Articles

Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine.

Yang X, Yang D, Qi X, Luo X, Zhang G Front Oncol. 2025; 14():1467033.

PMID: 39845328 PMC: 11753220. DOI: 10.3389/fonc.2024.1467033.


Role of PRMT1 and PRMT5 in Breast Cancer.

Martinez S, Sentis S, Poulard C, Tredan O, Le Romancer M Int J Mol Sci. 2024; 25(16).

PMID: 39201539 PMC: 11354362. DOI: 10.3390/ijms25168854.


Comparison of pain modulatory effect of the LPGi estragon receptor on inflammatory pain between pro-estrus and estrus phases and OVX rats.

Ansari S, Khahpay R, Khakpai F, Heidarzadeh Z, Khojasteh S Psychopharmacology (Berl). 2024; 242(1):129-147.

PMID: 39180591 DOI: 10.1007/s00213-024-06653-2.


Association Between Female Sex and Better Survival in Gastroenteropancreatic Neuroendocrine Tumors.

Chang J, Suraju M, Tran C, Chan C, Ear P, Howe J J Surg Res. 2024; 302:53-63.

PMID: 39083906 PMC: 11490409. DOI: 10.1016/j.jss.2024.07.012.


The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors.

Kranjcevic J, conkas J, Ozretic P Cancers (Basel). 2024; 16(8).

PMID: 38672656 PMC: 11049451. DOI: 10.3390/cancers16081575.


References
1.
Rau S, Dubal D, Bottner M, Gerhold L, Wise P . Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci. 2003; 23(36):11420-6. PMC: 6740516. View

2.
Santen R, Song R, Zhang Z, Yue W, Kumar R . Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer. Clin Cancer Res. 2004; 10(1 Pt 2):337S-45S. DOI: 10.1158/1078-0432.ccr-031207. View

3.
Song R, Barnes C, Zhang Z, Bao Y, Kumar R, Santen R . The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci U S A. 2004; 101(7):2076-81. PMC: 357054. DOI: 10.1073/pnas.0308334100. View

4.
Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M . S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun. 2004; 316(3):878-83. DOI: 10.1016/j.bbrc.2004.02.129. View

5.
Yu X, Rajala R, McGinnis J, Li F, Anderson R, Yan X . Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem. 2004; 279(13):13086-94. DOI: 10.1074/jbc.M313283200. View